This paper is in the following e-collection/theme issue:

Extended Reality, Virtual Reality and Virtual Worlds (761) Cancer and Clinical Trials (41) Chemotherapy and Side Effects Management (110) Clinical Integration of XR and Spatial Computing (59) Extended Reality, Virtual Reality and Virtual Worlds (761)

Published on in Vol 27 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/65924, first published .
Effect of Immersive Virtual Reality on Chemotherapy-Related Side Effects in Patients Receiving Paclitaxel-Carboplatin With or Without Bevacizumab: 2-Arm Randomized Controlled Trial

Effect of Immersive Virtual Reality on Chemotherapy-Related Side Effects in Patients Receiving Paclitaxel-Carboplatin With or Without Bevacizumab: 2-Arm Randomized Controlled Trial

Effect of Immersive Virtual Reality on Chemotherapy-Related Side Effects in Patients Receiving Paclitaxel-Carboplatin With or Without Bevacizumab: 2-Arm Randomized Controlled Trial

Authors of this article:

Kazuyuki Niki1 Author Orcid Image ;   Satoshi Nakagawa2 Author Orcid Image ;   Misaki Arai1 Author Orcid Image ;   Ayaka Morimoto1 Author Orcid Image ;   Yutaka Ueda2 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Kazuyuki Niki   1 , PhD ;   Satoshi Nakagawa   2 , MD, PhD ;   Misaki Arai   1 , BP ;   Ayaka Morimoto   1 , BP ;   Yutaka Ueda   2 , MD, PhD

1 Department of Clinical Pharmacy Research and Education, The University of Osaka Graduate School of Pharmaceutical Sciences, Osaka, Suita, Japan

2 Department of Obstetrics and Gynecology, The University of Osaka Graduate School of Medicine, Suita, Osaka, Japan

Corresponding Author:

  • Kazuyuki Niki, PhD
  • Department of Clinical Pharmacy Research and Education
  • The University of Osaka Graduate School of Pharmaceutical Sciences
  • Yamadaoka 1-6
  • Osaka, Suita 565-0871
  • Japan
  • Phone: 81 6-6879-8250
  • Email: k-niki@phs.osaka-u.ac.jp